Jennifer Jarrett's most recent trade in Sagimet Biosciences Inc - Ordinary Shares - Class A was a trade of 27,268 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sagimet Biosciences Inc - ... | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 27,268 | 27,268 | - | - | Stock Option (Right to Buy) | |
| Zura Bio Ltd - Ordinary Sh... | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 51,000 | 51,000 | - | - | Share Option (Right to Buy) | |
| Syndax Pharmaceuticals Inc | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 25,000 | 90,000 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 50,000 | 213,369 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.08 per share. | 15 Dec 2024 | 27,501 | 163,369 (0%) | 0% | 16.1 | 442,216 | Common Stock |
| Zura Bio Ltd - Ordinary Sh... | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 117,000 | 117,000 | - | - | Share Option (Right to Buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.95 per share. | 15 Sep 2024 | 12,670 | 190,394 (0%) | 0% | 18.0 | 227,427 | Common Stock |
| Sagimet Biosciences Inc - ... | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 113,895 | 113,895 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.97 per share. | 15 Jun 2024 | 12,670 | 203,064 (0%) | 0% | 17.0 | 215,010 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.55 per share. | 27 Mar 2024 | 11,551 | 215,253 (0%) | 0% | 17.5 | 202,720 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.84 per share. | 18 Mar 2024 | 12,153 | 228,100 (0%) | 0% | 17.8 | 216,810 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.62 per share. | 18 Mar 2024 | 1,296 | 226,804 (0%) | 0% | 18.6 | 24,132 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett Ann | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 26 Feb 2024 | 34,070 | 240,253 (0%) | 0% | 20.1 | 685,148 | Common Stock |
| Arcus Biosciences Inc | Ann Jennifer Jarrett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.07 per share. | 26 Feb 2024 | 24,555 | 274,323 (0%) | 0% | 20.1 | 492,819 | Common Stock |
| Syndax Pharmaceuticals Inc | Ann Jarrett Jennifer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 17,000 | 65,000 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 162,400 | 162,400 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 40,000 | 298,878 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jarrett Ann Jennifer | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.76 per share. | 22 Dec 2023 | 21,521 | 258,878 (0%) | 0% | 17.8 | 382,213 | Common Stock |
| Arcus Biosciences Inc | Ann Jarrett Jennifer | Director, Chief Operating Officer | Sale or transfer of securities back to the company at price $ 18.09 per share. | 18 Dec 2023 | 11,492 | 280,399 (0%) | 0% | 18.1 | 207,890 | Common Stock |
| Arcus Biosciences Inc | Ann Jennifer Jarrett | Director, Chief Operating Officer | Sale or transfer of securities back to the company at price $ 17.74 per share. | 18 Dec 2023 | 11,250 | 291,891 (0%) | 0% | 17.7 | 199,575 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.99 per share. | 22 Sep 2023 | 21,369 | 302,691 (0%) | 0% | 20.0 | 427,166 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale or transfer of securities back to the company at price $ 20.40 per share. | 18 Sep 2023 | 12,506 | 324,060 (0%) | 0% | 20.4 | 255,122 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.25 per share. | 28 Jul 2023 | 45,000 | 336,566 (0%) | 0% | 20.3 | 911,250 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.12 per share. | 22 Jun 2023 | 12,437 | 381,566 (0%) | 0% | 19.1 | 237,795 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.35 per share. | 16 Jun 2023 | 12,563 | 394,003 (0%) | 0% | 19.3 | 243,094 | Common Stock |
| Zura Bio Ltd - Ordinary Sh... | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 7,652 | 7,652 | - | - | Employee Share Option (Right to Buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.81 per share. | 16 Mar 2023 | 8,729 | 406,217 (0%) | 0% | 16.8 | 146,734 | Common Stock |
| Syndax Pharmaceuticals Inc | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 16,000 | 48,000 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.52 per share. | 26 Jan 2023 | 1,600 | 414,946 (0%) | 0% | 23.5 | 37,632 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.56 per share. | 26 Jan 2023 | 300 | 416,546 (0%) | 0% | 23.6 | 7,068 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 185,900 | 185,900 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 45,800 | 416,846 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.66 per share. | 16 Dec 2022 | 13,879 | 150,212 (0%) | 0% | 30.7 | 425,530 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.23 per share. | 16 Dec 2022 | 2,603 | 147,609 (0%) | 0% | 31.2 | 81,292 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 26.28 per share. | 16 Sep 2022 | 12,677 | 130,942 (0%) | 0% | 26.3 | 333,152 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.72 per share. | 16 Jun 2022 | 6,081 | 125,233 (0%) | 0% | 20.7 | 125,998 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.29 per share. | 16 Jun 2022 | 4,663 | 118,619 (0%) | 0% | 22.3 | 103,938 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.71 per share. | 16 Jun 2022 | 1,951 | 123,282 (0%) | 0% | 21.7 | 42,356 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.62 per share. | 16 Mar 2022 | 9,617 | 105,978 (0%) | 0% | 31.6 | 304,090 | Common Stock |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Jennifer Ann Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 31,250 | 121,845 (0%) | 0% | 0 | Common Stock | |
| Syndax Pharmaceuticals Inc | Jennifer Ann Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 16,000 | 32,000 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 41.70 per share. | 20 Dec 2021 | 20,923 | 93,395 (0%) | 0% | 41.7 | 872,458 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.88 per share. | 20 Dec 2021 | 11,099 | 114,318 (0%) | 0% | 40.9 | 453,677 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 42.23 per share. | 20 Dec 2021 | 2,800 | 90,595 (0%) | 0% | 42.2 | 118,234 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 39.59 per share. | 16 Dec 2021 | 4,064 | 134,031 (0%) | 0% | 39.6 | 160,900 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 41.42 per share. | 16 Dec 2021 | 2,575 | 125,417 (0%) | 0% | 41.4 | 106,666 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.57 per share. | 16 Dec 2021 | 1,955 | 127,992 (0%) | 0% | 40.6 | 79,321 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 38.79 per share. | 16 Dec 2021 | 1,580 | 130,955 (0%) | 0% | 38.8 | 61,285 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.46 per share. | 16 Dec 2021 | 1,496 | 132,535 (0%) | 0% | 40.5 | 60,523 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 39.67 per share. | 16 Dec 2021 | 1,008 | 129,947 (0%) | 0% | 39.7 | 39,989 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.06 per share. | 20 Sep 2021 | 21,900 | 130,309 (0%) | 0% | 35.1 | 767,814 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.50 per share. | 20 Sep 2021 | 11,981 | 117,728 (0%) | 0% | 35.5 | 425,326 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.48 per share. | 20 Sep 2021 | 8,134 | 152,209 (0%) | 0% | 35.5 | 288,610 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.98 per share. | 20 Sep 2021 | 4,885 | 112,843 (0%) | 0% | 36.0 | 175,762 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.67 per share. | 20 Sep 2021 | 600 | 129,709 (0%) | 0% | 35.7 | 21,402 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.68 per share. | 16 Jun 2021 | 4,863 | 135,343 (0%) | 0% | 23.7 | 115,156 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 24.13 per share. | 16 Jun 2021 | 3,809 | 140,365 (0%) | 0% | 24.1 | 91,911 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 24.77 per share. | 16 Jun 2021 | 159 | 140,206 (0%) | 0% | 24.8 | 3,938 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 24.91 per share. | 04 Jun 2021 | 1,044 | 119,174 (0%) | 0% | 24.9 | 26,006 | Common Stock |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.03 per share. | 16 Mar 2021 | 8,661 | 116,973 (0%) | 0% | 35.0 | 303,394 | Common Stock |
| Syndax Pharmaceuticals Inc | Jennifer Jarrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 16,000 | 16,000 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 400,000 | 500,634 (1%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Jennifer Jarrett | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) |